Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Drug Safety|April 20, 2016
Diagnosis and Management of Drug-Induced Liver Injury (DILI) in Patients with Pre-Existing Liver DiseaseRolf Teschke, Gaby DananDiagnostics (Basel, Switzerland)|October 23, 2021
The LiverTox Paradox-Gaps between Promised Data and Reality CheckRolf Teschke, Gaby DananInternational Journal of Molecular Sciences|July 14, 2023
Advances in Idiosyncratic Drug-Induced Liver Injury Issues: New Clinical and Mechanistic Analysis Due to Roussel Uclaf Causality Assessment Method UseRolf Teschke, Gaby DananDiagnostics (Basel, Switzerland)|July 12, 2025
Drug-Induced Autoimmune Hepatitis: Robust Causality Assessment Using Two Different Validated and Scoring Diagnostic AlgorithmsRolf Teschke, Axel Eickhoff, Gaby DananJGH Open : an Open Access Journal of Gastroenterology and Hepatology|November 29, 2018
Is obesity rather than the dietary supplement used for weight reduction the cause of liver injury?Rolf Teschke, Albrecht Wolff, Axel Eickhoff, et al.Translational Gastroenterology and Hepatology|August 23, 2021
Herb-induced liver injury (HILI) with 12,068 worldwide cases published with causality assessments by Roussel Uclaf Causality Assessment Method (RUCAM): an overviewRolf Teschke, Axel Eickhoff, Johannes Schulze, et al.Medicines (Basel, Switzerland)|September 21, 2017
Traditional Chinese Medicine (TCM) and Herbal Hepatotoxicity: RUCAM and the Role of Novel Diagnostic Biomarkers Such as MicroRNAsRolf Teschke, Dominique Larrey, Dieter Melchart, et al.International Journal of Molecular Sciences|April 12, 2017
Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment?Rolf Teschke, Johannes Schulze, Axel Eickhoff, et al.Pageof 2